Nureca Limited (NURECA) fundamentals
Nureca Limited is a listed company in Healthcare Equipment & Supplies, part of the Healthcare sector, listed on the NSE as NURECA (ISIN INE0DSF01015). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Nureca Limited does
Nureca Limited is a specialist in home healthcare and wellness products. Its products serve individuals, caregivers and medical practitioners across the globe. It offers a range of products specialized in home-based, non-invasive digital diagnosis and prevention of lifestyle diseases. Its range of products are spread across categories like respiratory wellbeing, physiotherapy, cardiac health monitoring, diabetes detection, mother and childcare and more. Its brands include Dr. Trust, trumom and Dr. Physio. Dr. Trust is a wellness and healthcare brand which provides medical devices and health monitoring solutions. trumom is a mother and childcare brand. Dr. Physio is an ortho and pain management brand. Its chronic devices include home monitoring devices and medical wearables that populate readings to identify health patterns. Its lifestyle products span weighing scales to yoga gear. Dr Trust 360 enables monitoring, analyses, storing and reporting of health data and patterns over time.
Valuation and market data
| Last close | ₹333.00 |
|---|---|
| Market capitalisation | ₹328 crore |
| Enterprise value | ₹328 crore |
| P/E (TTM) | 157.82 |
| Price to book | 1.82 |
| Price to sales (TTM) | 1.21 |
| Book value per share | ₹183.36 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Listed since | Thu Feb 25 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹155 crore | ₹5 crore | ₹2 crore | 2.11 |
| Mar 2025 | ₹122 crore | ₹1 crore | ₹1 crore | 0.85 |
| Mar 2024 | ₹102 crore | ₹-3 crore | ₹-2 crore | -1.79 |
| Mar 2023 | ₹118 crore | ₹-11 crore | ₹-8 crore | -8.25 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.1% |
|---|---|
| Foreign institutions (FII) | 0.1% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.2% |
| Retail and others | 31.6% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.